Viewing StudyNCT03538171



Ignite Creation Date: 2024-05-06 @ 11:30 AM
Last Modification Date: 2024-10-26 @ 12:46 PM
Study NCT ID: NCT03538171
Status: UNKNOWN
Last Update Posted: 2021-07-09
First Post: 2018-04-27

Brief Title: Ph3 Study of Exemestane With or Without Entinostat in Chinese Patients With Hormone Receptor-Positive Locally Advanced or Metastatic Breast Cancer
Sponsor: Taizhou EOC Pharma Co Ltd
Organization: Taizhou EOC Pharma Co Ltd

Conditions & Keywords Data

Conditions:
Name
Advanced Breast Cancer
Keywords: